nanoparticles – BioQuakes

In the world of science and medicine, new breakthroughs are always being made. In very recent news, a team of researchers from the University of California San Diego has created a game-changing biomaterial that could be the answer to treating tissue damage caused by heart attacks. This new discovery is not only exciting for those suffering from heart conditions, but it also showcases the importance of understanding cell and tissue repair in AP Biology.

Here’s how it works: the biomaterial, which can be injected intravenously or infused into a coronary artery in the heart, is made from a hydrogel derived from the extracellular matrix (ECM) of cardiac muscle tissue. The hydrogel forms a scaffold in damaged areas of the heart, promoting cell growth and repair. In previous studies, the team had already proven the effectiveness of the hydrogel when injected directly into the heart muscle. However, this method could only be used a week or more after a heart attack, as injecting sooner could cause damage during the procedure.

But this new biomaterial takes things to the next level. It’s put through a centrifuge to sift out larger particles, leaving only nano-sized particles, and then undergoes dialysis and sterile filtering before being freeze-dried. Adding sterile water to the final powder results in a material that can be infused into a blood vessel in the heart or injected intravenously, allowing for immediate treatment after a heart attack.

And that’s not all! The biomaterial was tested on rodent and porcine models of heart attacks, and researchers found that not only did it pass through blood vessels and into the tissue, but it also bound to cells and closed gaps in the blood vessels, reducing inflammation and accelerating healing. In addition, the team tested the hypothesis that the same biomaterial could help target inflammation in rat models of traumatic brain injury and pulmonary arterial hypertension.

So, why is this important from an AP Biology perspective? Well, in the course, we’ve learned about the body’s ability to repair and regenerate cells and tissues. By mimicking the B blood cells’ ability to reduce inflammation and react to an infection, this new biomaterial is a prime example of how that knowledge can be applied in the real world to help improve human health. It’s a new approach to regenerative engineering, and the possibilities of treating other difficult-to-access organs and tissues are endless.

The researchers, along with Ventrix Bio, Inc., a startup co-founded by lead researcher Karen Christman, are hoping to receive FDA authorization to conduct a study in humans within the next one to two years. This is exciting news for those affected by heart conditions, and we can’t wait to see what the future holds for this groundbreaking biomaterial.

Amid the global outbreak of COVID-19, with no end in sight after nearly two years, the future wellbeing of humans is in danger. Coughs, fevers, and shortness of breath have lent way to millions of deaths across the globe. As thousands of researchers relentlessly work to find solutions to this virus, multiple vaccine candidates have emerged. Specifically, in the United States, millions of Americans have received doses of the Pfizer-BioNTech, Moderna, and Johnson & Johnson’s Janssen vaccines. However, scientists at Scripps Research recently recognized a new, self-assembling COVID-19 vaccine as a potentially more efficient and effective way to fight this worldwide battle.

Primarily, it is critical to understand how vaccines function as they help protect the immune system. The COVID-19 vaccines currently in effect are mRNA-based; in other words, the messenger RNA signals one’s body to produce a harmless viral protein that resembles the structure of a spike protein. The body, with the help of T-Helper cells, recognizes this structure as a foreign invader as B cells bind to and identify the antigen. The T-Helper cells will then signal these B cells to form B-Plasma cells and B-Memory cells. When getting the vaccine, the B-Memory cells are especially important as they prevent reinfection. This is a process known as adaptive immunity. Here, in the event of future infection with the spike-protein COVID-19, the memory cells would help carry out the same response more quickly and efficiently. Essentially, this process acts as the body’s training in case of any future infections.

While the Scripps Research COVID-19 vaccine would evoke a similar immune response to that described above, it differs from other candidates in how it assembles in the human body; this new vaccine would be comprised of proteins that are able to self-assemble. On their own, these nanoparticle proteins would transform into a sphere protein structure surrounded by smaller proteins, mimicking the coronavirus’s shape. Here, the self-assembled spike proteins are more sturdy and stable than in an mRNA-produced structure. Thus, it more accurately prepares the body for future infection with COVID-19. In fact, multiple tests found that mice who were given the experimental vaccine were able to fight off not only SARS-CoV-2 but also SARS-CoV1 along with the alpha, beta and gamma variants.

Nonetheless, influencing the public to get a newer vaccine instead of the well-trusted vaccines already in production requires proof of the candidate’s benefits. Primarily, as mentioned, early results find that this new candidate would perform well with many different strains of COVID-19. Additionally, researchers assert that this vaccine would be relatively simple to produce on a mass scale. Lastly, scientists found that this vaccine may well be more protective and long-lasting than current vaccine candidates. Although the process of vaccine approval is lengthy and often difficult, I am hopeful for the future of the Scripps Research vaccine if it is put into production. Moreover, I believe that such experimentation with self-assembling nanoparticle proteins transcends the current pandemic. The benefits of this field present a wide array of opportunities, and I look forward to seeing what its future may hold.

What do you think? Are these transformer-like self-assembling particles a gateway to the future of medicine or an unnecessary distraction from effective treatments already in circulation?

BioQuakes

AP Biology class blog for discussing current research in Biology

Tag: nanoparticles

Biomaterial Breakthrough: A New Hope for Heart Attack Patients

Optimus Prime, Megatron, Proteins? The New Transformer Vaccine Candidate!

Archives